Cormorant Asset Management, LP Q2 2021 Filing

Filed August 16, 2021

Portfolio Value

$2.9T

Holdings

103

Report Date

Q2 2021

Filing Type

13F-HR

All Holdings (103 positions)

#StockSharesValue% PortfolioType
101
—CEREVEL THERAPEUTICS HLDNG I
19,316$278.0M0.01%
102
NUVB/WSNUVATION BIO INC
83,332$217.0M0.01%
103
—OUTLOOK THERAPEUTICS INC
416,666$130.0M0.00%
PreviousPage 2 of 2